MD Anderson Cancer Center shared on LinkedIn:
”At the 2024 American Association for Cancer Research Annual Meeting, our Samer Srour and Michael Migden presented results from two clinical trials highlighting novel immunotherapy advances, including a new allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer.
Learn about the findings.”